It’d be a monumental leap forward in the ongoing agony and ecstasy of treating wartime post-traumatic stress with psychedelics. They’d be somewhat unlikely partners, sure, but to hear that the Multidisciplinary Association for Psychedelic Studies has reached out to the Pentagon makes a lot of sense. MAPS needs PTSD-affected troops to fill out its trials, something the Pentagon undoubtedly can provide if it wants to.
Rick Doblin, MAPS founder and executive director, says the non-profit research group is in talks with the Pentagon about a potential study involving active duty soldiers with PTSD. He says that MAPS, which has been at the forefront of MDMA-, LSD-, and [...]
Schizophrenia is understood to be a long term, disabling mental condition with which the afflicted individual interprets reality abnormally. ‘Schizophrenic’ behavior includes, but is not limited to: faulty perception, mental fragmentation, withdrawal from reality into fantasy, and inappropriate actions and feelings which frequently causes schizophrenic individuals to be involuntarily committed to psychiatric hospitals for treatment. Is there really anything ‘wrong’ with the minds of schizophrenic individuals, or are the leaders of modern society, and society itself, afraid of allowing these individuals to embrace their altered perception?
Today, shamans and other mediums or [...]
A psychedelic drink used for centuries in healing ceremonies is now attracting the attention of biomedical scientists as a possible treatment for depression. Researchers from Brazil last month published results from the first clinical test of a potential therapeutic benefit for ayahuasca, a South American plant-based brew. Although the study included just six volunteers and no placebo group, the scientists say that the drink began to reduce depression in patients within hours, and the effect was still present after three weeks. They are now conducting larger studies that they hope will shore up their findings.The work forms part of a renaissance in studying the potential therapeutic [...]
For years, it has been believed that there could be a relationship between psychedelic use and the development of psychosis, psychological distress, and other mental conditions. Only recently has enough time passed to truly get an accurate analysis of the long term effects of the ‘classic’ psychedelics – LSD, mescaline, and psilocybin mushrooms – on the mind.
A study conducted by Neuroscientist Teri Suzanne Krebs and Clinical psychologist Pål-Ørjan Johansen of EmmaSofia published March 4th 2015 on Nature News conclusively shows no increased likeliness of mental health conditions in psychedelic users. The results of the study have been posted in the Journal of [...]
For some bizarre reason, there is not a state in the US that recognizes Autism as a qualifying condition to use cannabis medically, except in the case of California where doctors can prescribe cannabis to anyone they feel will benefit medicinally.
That’s not to say that activists in some states aren’t fighting and working hard to add Autism to the list, but with the endless stream of anecdotal and peer-reviewed evidence that proves that Autistic people function better using cannabis, it isn’t something we should have to fight for. It’s something we should be embracing right away.
In the Spring of 2014 we started working with our son’s new friend friend Noah to treat his [...]
Psychedelic therapy uses serotonergic (5-HT) psychedelics such as LSD, psilocybin, DMT, and 2C-B to assist with a non directive psychotherapy. This allows the patient to explore their psyche, all the while psychotherapy is occurring to help integrate the patient with the experience.  A patient on LSD may perceive family members distorted onto the psychiatrist being. This is called “perceptualizing the transference.”  The psychedelic scientific community is experiencing a resurgence in psychedelic therapy research which has been showing that psychedelics have treated PTSD, Depression, OCD, and Alcoholism.  In the 15 years that LSD was legal, beginning in the [...]
A new study conducted by Johns Hopkins Medical Institutions has found that single high doses of psilocybin, the active psychedelic compound in mushrooms, may bring on a positive personality change lasting at least a year in 60% of people.
Among the lasting changes were trains related to feelings, abstract ideas, open mindedness, aesthetics, and imagination. Changes in these traits varied widely, but could be validated scientifically and were larger in magnitude than changes observed in healthy adults over decades of ‘normal’ development.
“Normally, if anything, openness tends to decrease as people get older,” says study leader Roland R. Griffiths, a professor of [...]
For the first time since the 1970s, researchers are being allowed to study the potential medical properties of the most tightly controlled substances around. But it’s not easy.
When David Nichols earned a Ph.D in medicinal chemistry from the University of Iowa in 1973 by studying psychedelics, he thought he would continue studying hallucinogens indefinitely. “I thought I would work on it for the rest of my life,” he says.
His timing was less than fortuitous. In 1970, the year after Nichols started grad school, Richard Nixon signed into law the Controlled Substances Act, designed to clamp down on the manufacture and distribution of drugs in the U.S. The [...]
MAPS has recently completed the first double-blind, placebo-controlled study of the therapeutic use of LSD in human beings since the early 1970s.
LSD (lysergic acid diethylamide) is a semi-synthetic compound first developed in 1938 by Dr. Albert Hofmann at the Sandoz pharmaceutical company in Basel, Switzerland. After Dr. Hofmann first discovered its effects in 1943, LSD quickly became recognized for its possible therapeutic effects. LSD also played a significant role in the discovery of the serotonin neurotransmitter system.
Our recently completed Phase 2 pilot study in 12 [...]
After the wild breakout of Psychedelics during the 1960’s the ‘war on drugs’ put an immediate stop to any sort of research in to Psychedelics, potentially cutting off the human race from potential cures to many of the life changing conditions that our society is suffering so dramatically with today, conditions including Cancer, Depression, PTSD, Anxiety, Substance Abuse and the list goes on..
After more than 30 years of forced prohibition of these medicine,today we see many in the Scientific world begin to speak out about the benefits that these ancient plants can bring to not only the medical world but also for any individual interested in undertaking [...]
A 2012 Duke University study made international headlines when it purported to find a link between heavy marijuana use and IQ decline among teenagers. Other researchers questioned the findings almost immediately: Columbia University’s Carl Hart noted the very small sample of heavy users (38) in the study, leading him to question how generalizable the results were.
Then, a follow-up study published 6 months later in the same journal found that the Duke paper failed to account for a number of confounding factors: “Although it would be too strong to say that the results have been discredited, the methodology is flawed and the causal inference drawn from the results [...]
Scientific study often opens new doors of discovery—but sometimes it reopens doors closed long ago. On Tuesday, experimental psychiatrists in Santa Cruz, California published results from the first controlled medical trial of LSD in over 40 years.
The study, published in Journal of Nervous and Mental Disease[pdf], found evidence that LSD, when administered in a medically-based therapeutic environment, lowers the anxiety experienced by individuals facing life-threatening illnesses. Although the sample size—just 12 people—was small, the findings offer compelling rationale for further study of the illegal, often stigmatized drug.
“This study is historic and marks a [...]